维普中文期刊产品整合服务
27篇 您的检索式:作者名="Varettoni"
    题名 作者 年代 出处 被引量
1Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia:an effective but myelosuppressive regimen to be offered to patients with advanced disease显示文摘Tedeschi A Benevolo G Varettoni M 2012Cancer2012,118,2:1
2Incidence, presenting features and outcome of extrameduUary disease in multiple myeloma: a lon- gitudinal study on 1003 consecutive patients显示文摘Varettoni M Corso A Pica G 2010Ann Oncol2010,21,2:1
3Incidence, presenting features and outcome of extramedullary disease in multi- pie myeloma:a longitudina study on 1003 consecutive pa- tients显示文摘Varettoni M Corso A Pica G 2010Ann Onco2010,21,2:1
4A striking response to bortezomib in a patient with pleural localization of multiple myeloma 显示文摘Manqiaeavalli S Varettoni M Zappasodi P 2009Leukemia Research2009,33,4:1
5Distinctive Clinical and Histological Features of Waldenstr?m’s Macroglobulinemia and Splenic Marginal Zone Lymphoma显示文摘Luca Arcaini Marzia Varettoni Emanuela Boveri Ester Orlandi Sara Rattotti Silvia Zibellini Michele Merli Marco Lucioni Silvia Rizzi Manuel Gotti Lucia Morello Cristiana Pascutto Marco Paulli 2011Clinical Lymphoma Myeloma and Leukemia2011,,1:1
6Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia:an effective but myelosuppressive regimen to be offered to patients with advanced disease显示文摘Tedeschi A Benevolo G Varettoni M 2012Cancer2012,118,2:1
7Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients 显示文摘Varettoni M Corso A Pica G 2010Ann Oncol2010,21,2:1
8Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients显示文摘Varettoni M Corso A Pica G et al 2010Ann Oncol2010,21,2:1
9A different sched- ule of zoledronic acid can reduce the r/sk of the osteonecro- sis of the jaw in patients with multiple myeloma 显示文摘Corso A Varettoni M Zappasodi P 2007Leukemia2007,21,7:1
10Bortezomib plus dexametha-sone is highly effective in relapsed and refractory myeloma patients butresponses are short-lived显示文摘Corso A Varettoni M Mangiacavalli S e? al 2009Eur J Haematol2009,83,5:1
11Inci- dence, presenting features and outcome of extramedul- lary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients 显示文摘VARETTONI M CORSO A PICA G 2010Ann Oncol2010,21,2:1
12Incidence, presentingfeatures and outcome of extramedullary disease in multiplemyeloma: A longitudinal study on 1,003 consecutivepatients显示文摘Varettoni M Corso A Pica G 2009Ann Oncol2009,21,2:1
13Incidence,presenting features and outcome of extramedullary disease in multiple myeloma:a longitudinal study on 1003 consecutive patients显示文摘Varettoni M Corso A Pica G 0,,:1
14Prevalence and clinical significance of the MYD88 L265P somatic mutation in patients with Waldenstrom macroglobulinemia,IgM monoclonal gammopathy of undetermined significance or other mature B-cell neoplasms显示文摘Varettoni M Arcaini L Zibellini S 2012{H}Blood2012,,:1
15Incidence, presenting fea- tures and outcome of extramedullary disease in multiple myeloma : a longitudinal study on 1003 consecutive patients 显示文摘Varettoni M Corse A Pica G 2010Ann On- col2010,21,2:1
16Fludarabine plus eyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease 显示文摘Tedeschi A Benevolo G Varettoni M 2012Cancer2012,118,2:1
17Incidence, presentingfeatures and outcomes of extramedullary disease in multiplemyeloma: a longitudinal study on 1003 consecutive patients显示文摘Varettoni M Corso A Pica G 2010Ann Oncol2010,21,2:1
18Incidence, presenting features and outcome of extramedullary disease in multiple myeloma : a longitudinal study on 1003 consecutive patients 显示文摘VARETTONI M CORSO A PICA G 2010Ann Oncol2010,21,2:1
19Incidence,presentingfeatures and outcome of extramedullary disease in multi-ple myeloma : a longitudinal study on 1003 consecutive pa-tients 显示文摘Varettoni M Corso A Pica G 2010Ann Oncol2010,21,2:1
20Bortezomib-induced peripheral neuropathy in multiple myeloma: A comparison between previously treated and untreated patients 显示文摘CORSO A MANGIACAVALLI S VARETTONI M 2010Leuk Res2010,34,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费